Octreotide-LAR-associated erythema multiforme in an acromegalic subject: case report
Long-acting somatostatin analogs are often used for treating acromegaly, either as adjuvant to surgery or radiotherapy or, more recently, as a primary therapeutic option. These drugs seem to be reasonably safe, but new adverse effects not yet described may occur during the use of the relatively new long-acting formulations. In this case report, we describe a severe cutaneous reaction (erythema multiforme) in a patient treated with long-acting release (LAR) octreotide, and also discuss the need of previous "testing" with short subcutaneous preparation of octreotide.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Sociedade Brasileira de Endocrinologia e Metabologia
2008
|
| Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302008000100021 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|